NovaRx Mission

NovaRx’s mission is to treat cancer without the negative side effects typically associated with standard cancer treatment, which will greatly enhance the quality of life for patients. The company works to fulfill this mission by developing whole cell-based therapeutic vaccines for cancer that will improve patient outcomes by either curing the disease or effectively stabilizing it without adversely affecting quality of life.

NovaRx plans to carryout this vision at every level of the organization to ensure developed therapies such as Lucanix^® are approved as quickly as possible with exemplary clinical trial management and quality data. The Company has an unwavering commitment to establish NovaRx as a leader in biotechnology by conducting additional research to develop vaccines for other cancers. Should NovaRx realize this mission, the Company may be able to change the current paradigm for cancer management.